Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions. [electronic resource]
Producer: 20161014Description: 2470-3 p. digitalISSN:- 1468-3083
- Aged
- Aminoquinolines -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Double-Blind Method
- Face
- Facial Dermatoses -- drug therapy
- Female
- Humans
- Imiquimod
- Keratosis, Actinic -- drug therapy
- Male
- Middle Aged
- Scalp
- Scalp Dermatoses -- drug therapy
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.